ABCD Survey: Life as a diabetologist during the COVID-19 pandemic

Authors

  • Susannah Rowles Pennine Acute Hospitals NHS Trust
  • Dipesh Patel Royal Free Hospital, London
  • Andrew Macklin Dorset County Hospital
  • Umesh Dashora Conquest Hospital, Hastings

DOI:

https://doi.org/10.15277/bjd.2020.269

References

Dashora U, Patel DC, Gregory R, Winocour P, Dhatariya K, Nagi D. Association of British Clinical Diabetologists (ABCD) position statement on the use of sodium-glucose cotransporter-2 inhibitors in type 1 diabetes (updated 2019). Br J Diabetes 2019;19. https://doi.org/10.15277//bjd.2019.208 https://bjd-abcd.com/index.php/bjd/article/view/447

Kamrath C, Mönkmöller K, Biester T. Ketoacidosis in children and adolescents with newly diagnosed type 1 diabetes during the COVID-19 pandemic in Germany. JAMA 2020;324:801–04. https://doi.org/10.1001/jama.2020.13445 2. https://jamanetwork.com/journals/jama/fullarticle/2768716

Rabbone I, Schiaffini R, Cherubini V, et al. Has COVID-19 delayed the diagnosis and worsened the presentation of type 1 diabetes in children? Diabetes Care 2020;43. https://doi.org/10.2337/dc20-1321 3.https://care.diabetesjournals.org/content/early/2020/08/07/dc20-1321

Downloads

Published

2020-12-13

Most read articles by the same author(s)

1 2 3 4 5 6 7 > >>